We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.85B
AUM Growth
+$538M
Cap. Flow
+$255M
Cap. Flow %
6.63%
Top 10 Hldgs %
8.75%
Holding
1,265
New
117
Increased
828
Reduced
245
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 28.89%
2 Healthcare 14.73%
3 Industrials 11.24%
4 Energy 9.78%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBS icon
701
HubSpot
HUBS
$10.8B
$1.02M 0.03%
+1,545
New +$1.17M
LUV icon
702
Southwest Airlines
LUV
$22B
$1.02M 0.03%
23,705
+11,216
+90% +$527K
DXCM icon
703
DexCom
DXCM
$33.1B
$1.01M 0.03%
7,548
-6,716
-47% -$965K
GMAB icon
704
Genmab
GMAB
$19.2B
$1.01M 0.03%
25,494
-7,922
-24% -$330K
MRUS
705
DELISTED
Merus
MRUS
$1M 0.03%
+31,495
New +$890K
NTGR icon
706
NETGEAR
NTGR
$627M
$1M 0.03%
34,316
+1,166
+4% +$34.8K
WU icon
707
Western Union
WU
$2.19B
$1M 0.03%
56,215
-34,050
-38% -$628K
SBUX icon
708
Starbucks
SBUX
$119B
$996K 0.03%
8,508
-11,908
-58% -$1.34M
AAL icon
709
American Airlines Group
AAL
$9.93B
$989K 0.03%
55,067
-2,040
-4% -$39.1K
NBIS
710
Nebius Group N.V.
NBIS
$46.7B
$989K 0.03%
16,346
+1,324
+9% +$97.5K
TIL icon
711
Instil Bio
TIL
$50.3M
$988K 0.03%
2,886
-1,465
-34% -$565K
ATRA icon
712
Atara Biotherapeutics
ATRA
$77.6M
$986K 0.03%
2,502
-1,552
-38% -$653K
EXC icon
713
Exelon
EXC
$45.8B
$983K 0.03%
23,873
+359
+2% +$13.5K
RCUS icon
714
Arcus Biosciences
RCUS
$3.66B
$982K 0.03%
24,270
-34,311
-59% -$1.33M
QDEL icon
715
QuidelOrtho
QDEL
$943M
$980K 0.03%
7,257
+894
+14% +$124K
INBX
716
DELISTED
Inhibrx, Inc. Common Stock
INBX
$980K 0.03%
+22,450
New +$898K
BMI icon
717
Badger Meter
BMI
$3.95B
$978K 0.03%
9,180
+1,655
+22% +$174K
ELME
718
Elme Communities
ELME
$144M
$973K 0.03%
37,619
+485
+1% +$12.4K
FDX icon
719
FedEx
FDX
$76.9B
$964K 0.03%
3,730
-1,030
-22% -$247K
ALLO icon
720
Allogene Therapeutics
ALLO
$725M
$963K 0.03%
64,547
+7,968
+14% +$141K
DAL icon
721
Delta Air Lines
DAL
$58.7B
$963K 0.03%
24,628
+12,724
+107% +$509K
B
722
DELISTED
Barnes Group Inc.
B
$954K 0.02%
+20,492
New +$906K
GRWG icon
723
GrowGeneration
GRWG
$85.9M
$953K 0.02%
73,057
+3,627
+5% +$69.5K
HII icon
724
Huntington Ingalls Industries
HII
$13B
$952K 0.02%
5,094
+591
+13% +$114K
BB icon
725
BlackBerry
BB
$5.18B
$950K 0.02%
101,484
+8,953
+10% +$89.6K

Similar funds

Vident Investment Advisory's Q4 2021 Portfolio in Review

As of Q4 2021, Vident Investment Advisory held 1,265 positions worth $3.85B, up 16% from $3.31B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Vident Investment Advisory deployed $255M of net new capital in Q4 2021, opening 117 new positions and adding to 828 existing holdings. Its largest new stake was Vicarious Surgical: 35,777 shares worth $11.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iRhythm Holdings, an estimated $27.4M trimmed.

  • Vident Investment Advisory's largest Q4 2021 buy was Vicarious Surgical: 35,777 shares worth $11.4M.
  • Vident Investment Advisory added most to 3D Systems Corp in Q4 2021, an estimated $9.25M increase.
  • Vident Investment Advisory's biggest Q4 2021 reduction was iRhythm Holdings, cutting an estimated $27.4M.
  • Vident Investment Advisory fully exited Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) in Q4 2021, selling an estimated $27.4M.
  • Vident Investment Advisory's ten largest holdings make up 8.7% of its $3.85B portfolio in Q4 2021.
  • Vident Investment Advisory opened 117 new positions and closed 63 in Q4 2021.
  • Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.85B.

Based on Vident Investment Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.